Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms-Reference-Cited by-同舟云学术

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms

Published:2021-02-08 Issue:11 Volume:27 Page:3094-3105
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Tukachinsky Hanna^ORCID,Madison Russell W.^ORCID,Chung Jon H.^ORCID,Gjoerup Ole V.,Severson Eric A.,Dennis Lucas,Fendler Bernard J.,Morley Samantha,Zhong Lei,Graf Ryon P.,Ross Jeffrey S.^ORCID,Alexander Brian M.^ORCID,Abida Wassim,Chowdhury Simon,Ryan Charles J.,Fizazi Karim,Golsorkhi Tony^ORCID,Watkins Simon P.^ORCID,Simmons Andrew^ORCID,Loehr Andrea,Venstrom Jeffrey M.,Oxnard Geoffrey R.

Funder

Clovis Oncology, Inc

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing;ESMO Open;2024-09

2. Integration of expression datasets to identify biomarkers for accurate Gleason scoring in Prostate Cancer;2024-08-22

3. False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 Mutations;JCO Precision Oncology;2024-08

4. Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring;Aging;2024-07-19

5. Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution;Cancer Cell;2024-07